Availability: In Stock

Lehne’s Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants, 3rd Edition

ISBN: 9780323936064
Εκδόσεις:
Διαστάσεις 28 × 22 cm
Μορφή

Εκδόσεις

Ημ. Έκδοσης

Σελίδες

Έκδοση

Κύριος Συγγραφέας

,

Original price was: 141,00€.Η τρέχουσα τιμή είναι: 125,00€.(Περιλαμβάνεται ΦΠΑ 6%)

Διαθέσιμο - Προπαραγγελία|Διαθεσιμότητα: 11-14 ημέρες

Περιγραφή

Lehne’s Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants, 3rd Edition builds on the same foundation of clearly explained, up-to-date, and clinically current content as Lehne’s trusted undergraduate text, while focusing on the information that advanced practice nurses and Physician Assistants specifically need for safe and effective prescribing. Introductory chapters provide foundational content in the areas of prescriptive authority, rational drug selection, prescription writing, and promoting positive outcomes of drug therapy. Core drug chapters focus on the drugs that you will most commonly see in clinical practice. Pharmacotherapeutic decision-making is emphasized, with Black Box Warnings and new Drug Decision Guide boxes. This edition features completely updated content with new chapters on drugs for sexual dysfunction and drugs for transgender health. It’s everything you need to be a safe and effective prescriber!
Key Features
  • UPDATED! Content throughout reflects the latest drug information and evidence-based treatment guidelines and protocols.
  • NEW! Drugs for Sexual Dysfunction and Drugs for Transgender Health chapters in a newly combined Reproductive Health unit promote health equity.
  • NEW! Drug Decision Guide boxes for selected drugs emphasize a rational process for drug selection.
  • NEW! Clinical Pearls boxes highlight expert tips for rational drug prescription.
  • NEW! Chapter-opening Evolve links and “Top 300” drug icons throughout identify drugs that appear on the Top 300 prescribed drug list to help you focus your study time.
  • ENHANCED! Introductory chapters emphasize prescriber-level pharmacokinetics and pharmacodynamics content.
  • NEW! Coverage addresses immunizations and therapeutics (e.g., Regeneron, Resdemivir, dexamethasone) for SARS-CoV-2 infection (COVID-19).
  • UPDATED! Enhanced coverage of sexually transmitted infections reflects the latest evidence-based guidelines.
  • NEW! Drug content addresses medications for ectoparasite infestations.
  • Introductory chapters tailored to the specific needs of beginning prescribers cover topics such as prescriptive authority, rational drug selection and prescription writing, and promoting positive outcomes of drug therapy.
  • Carefully focused pharmacotherapeutics content reflects the drugs most commonly seen and used by primary and acute care prescribers, with an emphasis not on the first drug discovered or developed in each drug class, but on the agents most often used today.
  • Chapters address primary care drugs first, as appropriate, followed by acute care drugs.
  • Prescriber-focused pedagogical aids further reinforce the most important information for prescribers.
  • UNIQUE! Summary of Key Prescribing Considerations at the end of each drug chapter provides a concise summary of essential prescriber information.
  • Coverage of interprofessional collaboration addresses the growing global emphasis on interprofessional collaboration and incorporates opportunities for interprofessional collaborative practice throughout.
  • Integrated coverage of Canadian trade names appears throughout and is highlighted with a familiar maple-leaf icon.

Περιεχόμενα

UNIT I Introduction

1. Prescriptive Authority

2. Rational Drug Selection and Prescription Writing

3. Promoting Positive Outcomes of Drug Therapy
UNIT II Basic Principles of Pharmacology

4. Pharmacokinetics, Pharmacodynamics, and Drug Interactions

5. Adverse Drug Reactions and Medication Errors

6. Individual Variation in Drug Responses

7. Genetic and Genomic Considerations in Pharmacotherapeutics
UNIT III Drug Therapy Across the Life Span

8. Drug Therapy During Pregnancy and Breastfeeding

9. Drug Therapy in Pediatric Patients

10. Drug Therapy in Geriatric Patients
UNIT IV Peripheral Nervous System Drugs

11. Basic Principles of Neuropharmacology

12. Physiology of the Peripheral Nervous System

13. Muscarinic Agonists and Cholinesterase Inhibitors

14. Muscarinic Antagonists

15. Adrenergic Agonists

16. Adrenergic Antagonists

17. Indirect-Acting Antiadrenergic Agents
UNIT V Central Nervous System Drugs

18. Introduction to Central Nervous System Pharmacology

19. Drugs for Parkinson Disease

20. Drugs for Alzheimer Disease

21. Drugs for Seizure Disorders

22. Drugs for Muscle Spasm and Spasticity
UNIT VI Drugs for Pain

23. Local Anesthetics

24. Opioid Analgesics, Opioid Antagonists, and Nonopioid Centrally Acting Analgesics

25. Drugs for Headache
UNIT VII Psychotherapeutic Drugs

26. Antipsychotic Agents and Their Use in Schizophrenia

27. Antidepressants

28. Drugs for Bipolar Disorder

29. Sedative-Hypnotic Drugs

30. Management of Anxiety Disorders

31. Central Nervous System Stimulants and Attention-Deficit/Hyperactivity Disorder
UNIT VIII Substance Use Disorders

32. Substance Use Disorders I: Basic Considerations

33. Substance Use Disorders II: Alcohol

34. Substance Use Disorders III: Nicotine and Smoking

35. Substance Use Disorders IV: Major Drugs of Misuse Other Than Alcohol and Nicotine
UNIT IX Drugs That Affect the Heart, Blood Vessels, Blood, and Blood Volume

36. Review of Hemodynamics

37. Diuretics

38. Drugs Acting on the Renin-Angiotensin-Aldosterone System

39. Calcium Channel Blockers

40. Vasodilators

41. Drugs for Hypertension

42. Drugs for Heart Failure

43. Antidysrhythmic Drugs

44. Prophylaxis of Atherosclerotic Cardiovascular Disease: Drugs That Help Normalize Cholesterol and Triglyceride Levels

45. Drugs for Angina Pectoris

46. Anticoagulant and Antiplatelet Drugs

47. Drugs for Deficiency Anemias
UNIT X Drugs for Endocrine Disorders

48. Drugs for Diabetes

49. Drugs for Thyroid Disorders
UNIT XI Reproductive Health

50. Estrogens and Progestins: Basic Pharmacology and Noncontraceptive Applications

51. Birth Control

52. Androgens

53. Drugs for Benign Prostatic Hyperplasia

54. Drugs for Sexual Dysfunction

55. Transgender Health
UNIT XII Antiinflammatory, Antiallergic, and Immunologic Drugs

56. Review of the Immune System

57. Childhood Immunization

58. Antihistamines

59. Cyclooxygenase Inhibitors, Nonsteroidal Antiinflammatory Drugs, and Acetaminophen

60. Glucocorticoids in Nonendocrine Disorders
UNIT XIII Drugs for Bone and Joint Disorders

61. Drug Therapy for Rheumatoid Arthritis

62. Drug Therapy for Gout

63. Drugs Affecting Calcium Levels and Bone Mineralization
UNIT XIV Respiratory Tract Drugs

64. Drugs for Asthma and Chronic Obstructive Pulmonary Disease

65. Drugs for Allergic Rhinitis, Cough, and Colds
UNIT XV Gastrointestinal Drugs

66. Drugs for Peptic Ulcer Disease

67. Laxatives

68. Other Gastrointestinal Drugs
UNIT XVI Nutrition and Complementary Therapies

69. Vitamins

70. Drugs for Obesity

71. Complementary and Alternative Therapy
UNIT XVII Therapy for Infectious and Parasitic Diseases

72. Basic Principles of Antimicrobial Therapy

73. Drugs That Weaken the Bacterial Cell Wall I: Penicillins

74. Drugs That Weaken the Bacterial Cell Wall II: Other Drugs

75. Bacteriostatic Inhibitors of Protein Synthesis

76. Aminoglycosides: Bactericidal Inhibitors of Protein Synthesis

77. Sulfonamide Antibiotics and Trimethoprim

78. Drug Therapy for Urinary Tract Infections

79. Drug Therapy for Tuberculosis

80. Miscellaneous Antibacterial Drugs

81. Antifungal Agents

82. Antiviral Agents I: Drugs for Non-HIV Viral Infections

83. Antiviral Agents II: Drugs for HIV Infection

84. Drug Therapy for Sexually Transmitted Infections

85. Anthelmintics
UNIT XVIII Cancer Therapy

86. Introduction to Immunomodulators

87. Supportive Care of Patients Receiving Anticancer Drugs

88. Drugs for Cancer Pain
UNIT XIX Drugs for Eyes, Ears, and Skin

89. Drugs for Disorders of the Eye

90. Drugs for Disorders of the Skin

91. Drugs for Disorders of the Ear
UNIT XX Drug Therapy in Acute Care

92. Agents Affecting the Volume and Ion Content of Body Fluids

93. Management of ST-Elevation Myocardial Infarction

94. Drugs for Acute Care

Appendix: Canadian Drug Information
Index